Assessing the Role of Long-Acting Cabotegravir Preexposure Prophylaxis of Human Immunodeficiency Virus: Opportunities and Aspirations. - National Genomics Data Center (CNCB-NGDC)

Advanced Search

Assessing the Role of Long-Acting Cabotegravir Preexposure Prophylaxis of Human Immunodeficiency Virus: Opportunities and Aspirations.

Myron S Cohen, Raphael J Landovitz

Author Information

Myron S Cohen: Institute for Global Health and Infectious Diseases, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
Raphael J Landovitz: Center for Clinical AIDS Research and Education, University of California, Los Angeles, Los Angeles, California, USA.

PMID: 32882042 DOI: 10.1093/infdis/jiaa555

No abstract text available.

CAB LA HIV MSM PrEP TDF/FTC cabotegravir combination prevention long-acting

JAMA. 2019 Mar 5;321(9):844-845 [PMID: 30730529]
Ann Epidemiol. 2018 Dec;28(12):841-849 [PMID: 29983236]
AIDS Res Hum Retroviruses. 2018 Aug;34(8):645-656 [PMID: 29732896]
Open Forum Infect Dis. 2016 Jun 16;3(3):ofw125 [PMID: 27703992]
Clin Infect Dis. 2015 Jul 15;61(2):281-7 [PMID: 25870333]
Lancet HIV. 2019 Nov;6(11):e788-e799 [PMID: 31558423]
J Infect Dis. 2016 May 15;213(10):1523-31 [PMID: 26681778]
Lancet HIV. 2018 Sep;5(9):e498-e505 [PMID: 29908917]
AIDS. 2020 Nov 15;34(14):2103-2113 [PMID: 32910062]
N Engl J Med. 2020 Mar 19;382(12):1124-1135 [PMID: 32130806]
J Infect Dis. 2021 Jan 4;223(1):72-82 [PMID: 32882043]
Lancet HIV. 2020 Jul;7(7):e472-e481 [PMID: 32497491]
PLoS Med. 2018 Nov 8;15(11):e1002690 [PMID: 30408115]
Epidemics. 2020 Jan 24;30:100386 [PMID: 32004795]

R01 DK108424/NIDDK NIH HHS
UM1 AI068619/NIAID NIH HHS

HIV

HIV Infections

Humans

Models, Theoretical

Pre-Exposure Prophylaxis

Pyridones

Pyridones

cabotegravir

Editorial Research Support, N.I.H., Extramural Research Support, N.I.H., Intramural Comment